Celestial Biolabs
In the Dec 2023 quarter, revenue was ₹0.04 Cr, against ₹0.03 Cr a year earlier and net profit was −₹0.04 Cr, against −₹0.15 Cr a year earlier (compared with Dec 2022). Promoters held 26.07% of Celestial Biolabs in Mar 2024, unchanged from Dec 2023.
Peer Comparison
Healthcare › Pharmaceuticals & Biotechnology › Biotechnology
| ₹823.80 | 80.37 | 46,423 Cr | 15.25 | 0.24% | 19.45% | 26.78% | 2,161 Cr | 576 Cr | |
| ₹261.50 | 17.65 | 2,907 Cr | 1.79 | 2.05% | 10.31% | 13.58% | 800 Cr | 172 Cr | |
| ₹33.52 | — | 152 Cr | 3.79 | 0.00% | -0.35% | 0.87% | 0 Cr | -1 Cr | |
| ₹0.45 | — | 18 Cr | 0.28 | 0.00% | 0.59% | 0.81% | 7 Cr | -0 Cr | |
| ₹45.81 | 1,527.00 | 14 Cr | 3.56 | 0.00% | 9.13% | 11.32% | 0 Cr | 0 Cr | |
| Celestial Biolabs (this company) | — | — | — | — | — | — | — | 0 Cr | — |
| Median 6 companies | ₹45.81 | 80.37 | 152 Cr | 3.56 | 0.00% | 9.13% | 11.32% | 3 Cr | 0 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 2 companies are not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Weaknesses
4- Company has low interest coverage ratio.
- Contingent liabilities of Rs.1.29 Cr.
- Company might be capitalizing the interest cost
- Company has high debtors of 7,966 days.
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0.06 | 0.06 | 0.04 | 0.03 | 0.04 | 0.02 | 0.04 | 0.04 |
| Expenses | 0.33 | 0.15 | 0.11 | 0.18 | 0.27 | 0.11 | 0.07 | 0.07 |
| Operating Profit | -0.27 | -0.09 | -0.07 | -0.15 | -0.23 | -0.09 | -0.03 | -0.03 |
| OPM % | -450% | -150% | -175% | -500% | -575% | -450% | -75% | -75% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| PBT | -0.28 | -0.1 | -0.08 | -0.16 | -0.25 | -0.1 | -0.04 | -0.04 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.28 | -0.1 | -0.08 | -0.15 | -0.24 | -0.1 | -0.03 | -0.04 |
| EPS (₹) | -0.12 | -0.04 | -0.04 | -0.07 | -0.11 | -0.04 | -0.01 | -0.02 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|
| Sales | 0.15 | 0.17 | 0.14 |
| Expenses | 0.49 | 0.71 | 0.52 |
| Operating Profit | -0.34 | -0.54 | -0.38 |
| OPM % | -226.67% | -317.65% | -271.43% |
| Other Income | 0 | 0 | 0 |
| Interest | 0.04 | 0.01 | 0.01 |
| Depreciation | 0.03 | 0.03 | 0.04 |
| PBT | -0.41 | -0.58 | -0.43 |
| Tax % | 0% | 0% | — |
| Net Profit | -0.41 | -0.58 | -0.41 |
| EPS (₹) | -0.18 | -0.26 | -0.18 |
| Div. Payout % | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Sep 2023 |
|---|---|---|---|
| Equity Capital | 22.59 | 22.59 | 22.59 |
| Reserves | -19.24 | -19.81 | -19.94 |
| Borrowings | 11.54 | 12.03 | 12.04 |
| Other Liabilities | 2.29 | 2.43 | 2.49 |
| Total Liabilities | 17.18 | 17.24 | 17.18 |
| Fixed Assets | 0.1 | 0.08 | 0.06 |
| CWIP | 12.82 | 12.82 | 12.82 |
| Investments | 0 | 0 | 0 |
| Other Assets | 4.26 | 4.34 | 4.3 |
| Total Assets | 17.18 | 17.24 | 17.18 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 |
|---|---|---|
| Operating | -0.28 | -0.36 |
| Investing | 0 | 0 |
| Financing | 0.26 | 0.38 |
| Net Cash Flow | -0.02 | 0.02 |
| Free Cash Flow | -0.28 | -0.37 |
| CFO/EBITDA | 82 | 67 |
Ratios
| Particulars | Mar 2022 | Mar 2023 |
|---|---|---|
| Debtor Days | 9,320 | 7,966 |
| Inventory Days | 86.9 | 99.55 |
| Days Payable | 452 | 1,161 |
| Cash Conversion Cycle | 8,955 | 6,904 |
| Working Capital Days | -2,628 | -2,512 |
| ROCE % | — | -3.84% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Celestial Biolabs insights
54 extracted metrics + investor summaries across FY09–FY24.
Documents
Frequently Asked Questions about Celestial Biolabs
What does Celestial Biolabs Ltd do?
Where is Celestial Biolabs Ltd (CELESTIAL) listed?
Which sector does Celestial Biolabs Ltd belong to?
Company Information
Celestial Biolabs is engaged in activities of manufacturingof Ayurvedic products and Trading of Feed suppliments.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CELESTIAL.md for Celestial Biolabs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.